iScience Interventional

Medical Devices & EquipmentSeries GMenlo Park, USiscienceinterventional.com

Latest round

Series G

Last raised

Jan 2012

Total raised

$74M

Investors

10

About iScience Interventional

iScience Interventional Inc.Founded in 1999 and headquartered in Menlo Park, US, iScience Interventional specializes in medical devices for treating retinal diseases. The company has completed 12 deals, with its most recent deal occurring on January 20, 2014.iScience Interventional specializes in developing advanced medical technologies aimed at enhancing patient outcomes in the field of interventional ophthalmology. Their core product offerings include innovative devices designed for the treatment of various ocular conditions, specifically targeting the management of retinal diseases. These products are engineered to facilitate procedures that optimize vision restoration and improve the quality of life for patients suffering from such ailments. The company's solutions are utilized by healthcare professionals in hospitals and outpatient settings, serving a diverse client base that includes ophthalmologists, surgeons, and healthcare institutions across North America, Europe, and Asia.iScience Interventional generates revenue primarily through direct sales of its proprietary medical devices to healthcare facilities and practitioners. Transactions typically involve the sale of flagship products through established distribution channels, ensuring accessibility to medical professionals. The pricing structure reflects the advanced technology and clinical efficacy of their offerings.iScience Interventional is focused on expanding its market reach and product offerings. Following its recent acquisition by Ellex Medical Lasers Limited in January 2014, the company is expected to leverage this partnership to enhance its product development efforts. Plans include launching new medical devices targeting additional ocular conditions by 2025, with a focus on entering emerging markets in Asia and South America to facilitate broader access to its technologies.

Who invested in iScience Interventional

10 investors across 8 rounds

See all investors in iScience Interventional

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series G

    Jan 30, 2012

    Amount

    $2.8M

    Investors

    Locked

  2. Series G

    Aug 16, 2011

    Amount

    $3M

    Investors

    Locked

  3. Series F

    May 5, 2009

    Amount

    $21M

    Investors

    Locked

  4. Series E

    Apr 23, 2009

    Amount

    $2M

    Investors

    Locked

  5. Series E

    Mar 28, 2007

    Amount

    $20M

    Investors

    Locked

  6. Series D

    Apr 20, 2006

    Amount

    $4M

    Investors

    Locked

  7. Series C

    Apr 2, 2005

    Amount

    $15M

    Investors

    Locked

  8. Series B

    Apr 20, 2003

    Amount

    $7M

    Investors

    Locked

Questions about iScience Interventional

Who invested in iScience Interventional?

iScience Interventional has 10 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has iScience Interventional raised?

iScience Interventional has raised 8 venture rounds. Sign up free to see how much each round raised and the total.

When did iScience Interventional last raise money?

iScience Interventional's most recent round on record is a Series G, in Jan 2012.

What does iScience Interventional do?

iScience Interventional is a medical devices & equipment company.

Where is iScience Interventional headquartered?

iScience Interventional is headquartered in Menlo Park, US.

Which VCs invest in companies like iScience Interventional?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at iScience Interventional's stage. Their profiles are linked below.

Raising like iScience Interventional? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.